Lexicon Pharmaceuticals, Inc. earnings per share and revenue

LXRX earnings per share for the last quarter are -0.17 USD whereas the estimation was -0.18 USD which accounts for 3.95% surprise. Company revenue for the same period amounts to 1.65 M USD despite the estimated figure of 3.44 M USD. Estimated earnings per share for the next quarter are -0.16 USD, and revenue is expected to reach 2.93 M USD. Also watch annual changes over time to get a bigger picture of LXRX earnings per share and revenue dynamics.